Coronavirus vaccine: Moderna, Inovio, Pfizer -- who will win the race?
US-based biotechnology company Moderna on Monday said the preliminary findings of its test for coronavirus vaccine development have shown "favourable" results; Beth Israel Deaconess Medical Center has published research showing that a prototype vaccine effectively protected monkeys from infection with virus

- May 21, 2020,
- Updated May 21, 2020 3:56 PM IST
More than 100 research teams of various pharma companies and research institutions across the world are vying to produce a vaccine in shortest possible time. Some are ahead in the race and have started human trials, while others are exploring unconventional approaches to develop vaccine.
Pennsylvania, United States, based Inovio and New York-based pharma giant Pfizer and Oxford University's Jenner Institute are already at the human trials stage. All hope their vaccines to be ready to use by September.
More than 100 research teams of various pharma companies and research institutions across the world are vying to produce a vaccine in shortest possible time. Some are ahead in the race and have started human trials, while others are exploring unconventional approaches to develop vaccine.
Pennsylvania, United States, based Inovio and New York-based pharma giant Pfizer and Oxford University's Jenner Institute are already at the human trials stage. All hope their vaccines to be ready to use by September.